Skip to main content
. 2022 Mar 24;10(3):e003924. doi: 10.1136/jitc-2021-003924

Figure 4.

Figure 4

Time plots of mean dostarlimab and niraparib serum pharmacokinetic concentration by treatment and cycle. Mean (±SD) dostarlimab serum concentration by treatment as semi-logarithmic curves for dostarlimab cycle 1 (A), dostarlimab cycle 5 (B), niraparib cycle 1 (C), and niraparib cycle 2 (D).